Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer
Health Populi
AUGUST 16, 2021
bn for patient spending on branded drug cost-sharing after accounting for manufacture-financed support. There is one health care public policy issue that unites U.S. voters across political party: that is the consumer-facing costs of prescription drugs. Exhibit 3 shows these costs for each stakeholder, totaling $93 billion.
133 
Let's personalize your content